Morgan Stanley initiates coverage on Ashland stock with Equalweight rating

Published 08/09/2025, 07:50
Morgan Stanley initiates coverage on Ashland stock with Equalweight rating

Investing.com - Morgan Stanley initiated coverage on Ashland Inc. (NYSE:ASH) with an Equalweight rating and a $60.00 price target on Monday. Currently trading at $54.91, InvestingPro analysis suggests the stock is undervalued, with additional insights available in the comprehensive Pro Research Report.

The investment bank positioned Ashland within the chemicals quality-to-commodity spectrum, noting that the company has recently de-rated toward commodity names amid a prolonged turnaround story and concerns over less defensive core EBITDA. The company maintains strong financial fundamentals with a current ratio of 2.68, indicating liquid assets well exceed short-term obligations.

Morgan Stanley acknowledged that while the stock appears inexpensive with a relatively attractive Bull Case of $95 compared to a Bear Case of $35, confidence in key upside drivers depends on present-day EBITDA power being fully de-risked.

The firm identified self-help initiatives and innovation as potential catalysts for upside but expressed uncertainty about these factors materializing.

Morgan Stanley projects a wide range of potential outcomes for Ashland’s fiscal 2026 EBITDA, with Bear-to-Bull scenarios ranging from approximately $380 million to $480 million.

In other recent news, Ashland Inc . reported its fiscal third-quarter 2025 earnings, which fell short of analyst expectations. The company posted an adjusted earnings per share (EPS) of $1.04, below the anticipated $1.24, while revenue reached $463 million, missing the projected $476.58 million. Despite these results, Ashland announced a quarterly cash dividend of $0.415 per share, payable on September 15, 2025, to shareholders on record as of September 1, 2025.

Analyst firms have provided mixed assessments of Ashland’s stock. BMO Capital increased its price target to $61, attributing this to a higher EBITDA estimate for 2026. In contrast, Argus lowered its price target to $65, citing reduced demand and inflationary pressures impacting Ashland’s recent earnings. However, Argus maintains a positive outlook, expecting conditions to improve and recognizing Ashland as a well-managed company. These developments provide investors with a varied perspective on Ashland’s financial health and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.